Trending...
- 76 FENCE Expands in North Carolina with Strategic Franchise Growth Led by Regional Developer Drew Myers
- Celebrate Christmas 2024 with Exclusive Deals and Festive Offers
- Eva Garland Consulting Expands to New Office Space in Raleigh to Support Growing Accounting Team
AVENTURA, Fla. - ncarol.com -- Dr. Jeff Gelblum, Neurologist at First Choice Neurology, has brought together clinical, imaging, and laboratory capabilities to provide rapid diagnosis and treatment to individuals suffering from Alzheimer's disease.
The patient journey of Alzheimer's evaluation and management involves a clinical assessment to determine the level of cognitive impairment, and imaging studies of the brain, MRI, and PET scans to identify the presence of brain amyloid plaques. Also included are laboratory capabilities to inform the tolerability of the new anti-Alzheimer medication, and an experienced infusion team capable of providing the new class of FDA-approved medication in a comfortable setting.
Dr. Gelblum's highly integrated program will eliminate the long delays and fragmented care that typically plague patients seeking Alzheimer's treatment.
He observes, "that the new class of disease-modifying treatments are only approved in mild Alzheimer's which offers only a short window of opportunity to treat. In the US and abroad, it can often take up to a year to get a neurology appointment, and by that point, the patient may have progressed to a point where they might no longer respond to treatment."
More on ncarol.com
Dr. Gelblum's program eliminates the delay and provides a quick and comprehensive work-up in the Aventura medical district, just north of Miami, Florida.
Dr. Gelblum boasts that "within 48 hours we can diagnose and begin infusion therapy. This means that the patient can check in to our on-campus hotel on a Tuesday evening, undergo evaluation in our clinic Wednesday morning, receive diagnostic testing Wednesday and Thursday, and then obtain their infusion treatment on Friday."
For those patients who reside out of town, his infusion center can dispense medication to-go for follow-up infusion treatments in their hometown medical facility. This is ideal for out-of-town patients who may not have easy access to a neurologist. He can then follow the patient remotely via telehealth.
His Aventura clinic is easily accessible via Miami or Fort Lauderdale international airports.
Dr. Gelblum has a global patient population who has discovered the ease of access and convenience of care provided by this program. He has patients from the UK, Spain, France, Israel, Russia, South Korea, Central and South America, and the Caribbean. They are diagnosed in his Aventura clinic and then followed up remotely via Skype, WhatsApp, FaceTime, or any manner of live audiovisual interface.
More on ncarol.com
Dr. Gelblum observes, "that in this day and age of disease-modifying therapy and instantaneous telecommunications, it is unacceptable for medically necessary neurological care and treatment to be delayed."
He looks forward to welcoming Alzheimer patients from all over to his Aventura, Florida clinic.
About Jeffrey Gelblum, MD, FAAN
Dr. Jeff Gelblum is a neurologist with First Choice Neurology located in Aventura, Florida. He is considered a global thought leader in the neurologic treatment of Alzheimer's, dementia, seizure disorders, Parkinson's, diabetic and peripheral nerve disorder, Familial Amyloid Polyneuropathy, Covid Long-Hauler, trauma, and chronic pain, and has hosted educational symposia in the U.S. and overseas. To learn more about Dr. Gelblum, visit https://www.fcneurology.net/business-directory/788/jeffrey-gelblum-md/
The patient journey of Alzheimer's evaluation and management involves a clinical assessment to determine the level of cognitive impairment, and imaging studies of the brain, MRI, and PET scans to identify the presence of brain amyloid plaques. Also included are laboratory capabilities to inform the tolerability of the new anti-Alzheimer medication, and an experienced infusion team capable of providing the new class of FDA-approved medication in a comfortable setting.
Dr. Gelblum's highly integrated program will eliminate the long delays and fragmented care that typically plague patients seeking Alzheimer's treatment.
He observes, "that the new class of disease-modifying treatments are only approved in mild Alzheimer's which offers only a short window of opportunity to treat. In the US and abroad, it can often take up to a year to get a neurology appointment, and by that point, the patient may have progressed to a point where they might no longer respond to treatment."
More on ncarol.com
- Capital Realty Group Has An Outstanding October!
- The United States Environmental Protection Agency (USEPA) is SEBAC's 2024 Award for Excellence winner
- Author Riley G. Staliger Offers Tools to Escape Guilt-Driven Relationships AKA Obligationships Using Pop Culture
- Healthcare Consulting Firm, Coker, Announces Acquisition of NorthGauge Healthcare Advisors
- Kaplan Morrell Named Exclusive Workers' Compensation Firm for Greeley Fire Fighters
Dr. Gelblum's program eliminates the delay and provides a quick and comprehensive work-up in the Aventura medical district, just north of Miami, Florida.
Dr. Gelblum boasts that "within 48 hours we can diagnose and begin infusion therapy. This means that the patient can check in to our on-campus hotel on a Tuesday evening, undergo evaluation in our clinic Wednesday morning, receive diagnostic testing Wednesday and Thursday, and then obtain their infusion treatment on Friday."
For those patients who reside out of town, his infusion center can dispense medication to-go for follow-up infusion treatments in their hometown medical facility. This is ideal for out-of-town patients who may not have easy access to a neurologist. He can then follow the patient remotely via telehealth.
His Aventura clinic is easily accessible via Miami or Fort Lauderdale international airports.
Dr. Gelblum has a global patient population who has discovered the ease of access and convenience of care provided by this program. He has patients from the UK, Spain, France, Israel, Russia, South Korea, Central and South America, and the Caribbean. They are diagnosed in his Aventura clinic and then followed up remotely via Skype, WhatsApp, FaceTime, or any manner of live audiovisual interface.
More on ncarol.com
- Drive for Gratitude Significantly Impacts Veterans Well-being
- The Voice of the Wooden Dragon is Latest Release from NFB Publishing
- AONE Fest 2024: Celebrating Creativity and Community at Red Dot Studios
- Alterra Retail Introduces Premium Baby Clothes Made from Organic Pima Cotton
- At Your Service Plumbing Honored with Silver Award in The Best of Pierce County
Dr. Gelblum observes, "that in this day and age of disease-modifying therapy and instantaneous telecommunications, it is unacceptable for medically necessary neurological care and treatment to be delayed."
He looks forward to welcoming Alzheimer patients from all over to his Aventura, Florida clinic.
About Jeffrey Gelblum, MD, FAAN
Dr. Jeff Gelblum is a neurologist with First Choice Neurology located in Aventura, Florida. He is considered a global thought leader in the neurologic treatment of Alzheimer's, dementia, seizure disorders, Parkinson's, diabetic and peripheral nerve disorder, Familial Amyloid Polyneuropathy, Covid Long-Hauler, trauma, and chronic pain, and has hosted educational symposia in the U.S. and overseas. To learn more about Dr. Gelblum, visit https://www.fcneurology.net/business-directory/788/jeffrey-gelblum-md/
Source: First Choice Neurology
0 Comments
Latest on ncarol.com
- Ghostly Gamble: Nick Caden's Deadliest Halloween Mystery Yet
- Cornerstone Hospitality Solutions, Llc Receives Veteran Institute For Procurement Commercial Certification
- Summit Credit Union Reaffirms Commitment to Small Credit Unions and Women's Leadership with New $130,000 Contribution
- Upcoming Webinar: Family-Owned Businesses in Italy and Spain: Opportunities and Pitfalls for International Investors
- WYSIWYG Marketing Welcomes Ellen McColl as Director of Business Development
- Inc. Names BYLTup as a 2024 Power Partner Award Winner
- Gateway Center Arena Welcomes Atlantans To The City's Premier Sports and Entertainment Venue
- Support Literacy and Community Well-Being: Buy or Send a New Book to a Child in Need Today!
- WE In The World, Supported By Robert Wood Johnson Foundation, Calls Healthcare & Community Changemakers To Transform Structural Racism in Healthcare
- Arbutus Medical Launches Digit Revision SwiftKit™ to Streamline Trauma Care and Improve Emergency Department Throughput
- MarketTecNexus CEO's Digital Clone Introduces "AI Business Scale Up™," Services Redefining AI Transformation for Mid-Size Businesses
- Cresimore Joins Presidia Asset Management as Director of Business Development, and Investor Relations
- Los Defensores Champions Underserved Communities with the Launch of "Siempre Contigo" Initiative in Houston
- Natural Sweetener Health Trend on the Rise: Black Friday Special Discounts Are Here!
- First Citizens BancShares Declares Dividends
- TOKYO SKYTREE® is Now Selling Premium Traditional Performing Arts Experiences
- Vantiva and e& Deploy First eSIM-enabled 5G Fixed Wireless Access Gateway for United Arab Emirates Subscribers
- OpsVeda Announces General Availability Of Release 10.0 Of Its AI Powered Operations Command Center
- Celebrate Christmas 2024 with Exclusive Deals and Festive Offers
- Klatt Works, Executive Flightways, L2 Aviation, and Ametek Revolutionize Business Jet Safety with the First SAVED System STC for the G550